Literature DB >> 12773454

Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles.

Jeffrey Boldt1, Donald Cline, David McLaughlin.   

Abstract

BACKGROUND: The purpose of this work was to develop methods for successful cryopreservation of human oocytes.
METHODS: Two cryopreservation procedures were used. Method 1 involved use of 1.5 mol/l propanediol (PrOH)-0.1 mol/l sucrose with medium containing sodium (Na) as cryoprotectant medium, seeding at -7 degrees C, and stepwise dilution of cryoprotectant post-thaw. Method 2 used Na-depleted media with 1.5 mol/l PrOH-0.2 mol/l sucrose for freezing, seeding at -6 degrees C, and use of high sucrose (0.5 and 0.2 mol/l) for cryoprotectant removal.
RESULTS: The first method was used in seven patients, and gave poor (12.3%) survival results and no pregnancies. The second method was used in 15 patients (16 cycles), and yielded good survival and fertilization rates (74.4 and 59% respectively), with four pregnancies and five healthy infants born to 11 women receiving an embryo transfer.
CONCLUSIONS: Using Na-depleted media along with other alterations in freezing and thawing procedures, human oocyte cryopreservation can provide excellent survival and pregnancy rates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773454     DOI: 10.1093/humrep/deg242

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Effects of duration of cryo-storage of mouse oocytes on cryo-survival, fertilization and embryonic development following vitrification.

Authors:  Jie Yan; Joao Suzuki; Xiao-Min Yu; Jie Qiao; Frederick W K Kan; Ri-Cheng Chian
Journal:  J Assist Reprod Genet       Date:  2011-05-04       Impact factor: 3.412

Review 2.  Oocyte cryopreservation: is it time to remove its experimental label?

Authors:  Nicole Noyes; Jeffrey Boldt; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2010-02-06       Impact factor: 3.412

3.  Maturation outcomes are improved following Cryoleaf vitrification of immature human oocytes when compared to choline-based slow-freezing.

Authors:  Catherine M H Combelles; S Temel Ceyhan; Haiyan Wang; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2011-11-17       Impact factor: 3.412

4.  Oocyte cryopreservation: the birth of the first Hungarian babies from frozen oocytes.

Authors:  Janos Konc; Katalin Kanyo; Erika Varga; Rita Kriston; Sandor Cseh
Journal:  J Assist Reprod Genet       Date:  2008-07-30       Impact factor: 3.412

5.  Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles.

Authors:  Min Xu; Erin R West-Farrell; Richard L Stouffer; Lonnie D Shea; Teresa K Woodruff; Mary B Zelinski
Journal:  Biol Reprod       Date:  2009-05-27       Impact factor: 4.285

6.  Fertility preservation for women with malignancies: current developments of cryopreservation.

Authors:  Hye Jin Chang; Chang Suk Suh
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

7.  Human oocyte vitrification: the permeability of metaphase II oocytes to water and ethylene glycol and the appliance toward vitrification.

Authors:  Steven F Mullen; Mei Li; Yuan Li; Zi-Jiang Chen; John K Critser
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

8.  Developments in IVF legislation in a Catholic country.

Authors:  Pierre Mallia
Journal:  Med Health Care Philos       Date:  2013-08

9.  Comparison of selected cryoprotective agents to stabilize meiotic spindles of human oocytes during cooling.

Authors:  Dunsong Yang; Kevin L Winslow; Kevin Nguyen; Daniel Duffy; Michael Freeman; Talha Al-Shawaf
Journal:  J Exp Clin Assist Reprod       Date:  2010-10-04

10.  Mouse oocyte vitrification with and without dimethyl sulfoxide: influence on cryo-survival, development, and maternal imprinted gene expression.

Authors:  Clementina Cantatore; Jenny S George; Raffaella Depalo; Giuseppe D'Amato; Molly Moravek; Gary D Smith
Journal:  J Assist Reprod Genet       Date:  2021-05-22       Impact factor: 3.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.